(Corrects the third paragraph to add billion in the consideration)
Don Agro International's (SGX:GRQ) wholly owned subsidiary, JSC Tetra, entered into agreements for the acquisition of a majority stake in 812 Capital and a minority stake in the Centre for Innovative Medical Technologies (CIMT), according to a filing with the Singapore Exchange on Thursday.
The company entered into an agreement with Khvicha Akubardia and Aleksander Sviridov for the acquisition of a 99.99% stake in 812 Capital and the acquisition of an 11.50% stake in CIMT.
The aggregate consideration payable is 3.04 billion Russian rubles.
812 Capital is a federal network of oncology clinics and the acquisition will provide Don Agro recurrent business activities to meet requirements for a new listing.
Shares of the company slumped nearly 20% in recent trading.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。